• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 56 of 100
Former Turing Pharmaceuticals CEO Martin Shkreli Case Nears End As Lawyers Prepare For Final Argument
TechA New ICO Wants to Get That Wu-Tang Album Out of Martin Shkreli’s Hands
By David Z. MorrisSeptember 25, 2017
How a 32-Year-Old CEO Got a Team of Pharma Vets to Join His Radical Approach to Making Drugs
HealthHow a 32-Year-Old CEO Got a Team of Pharma Vets to Join His Radical Approach to Making Drugs
By Sy MukherjeeSeptember 21, 2017
Big Pharma Turns to Blockchain to Track Meds
The LedgerBig Pharma Turns to Blockchain to Track Meds
By Jeff John RobertsSeptember 21, 2017
Bioreactors at Cook Pharmica's facility in Bloomington, Ind.
HealthCook Pharmica Sells to Catalent in $950 Million Biopharma Deal
By Andrew NuscaSeptember 19, 2017
The Walgreen Co. logo is displayed in the cosmetics section of one of the company's stores in Kentucky.
RetailWalgreens Has Finally Been Cleared to Buy Almost 2,000 Rite Aid Stores
By ReutersSeptember 19, 2017
An Amgen sign is seen at the company's office in South San Francisco
HealthAmgen Is Taking On a $3 Billion Cancer Drug. But Will It Cut Costs for Patients?
By Sy MukherjeeSeptember 15, 2017
Jury Deliberations Continue In Martin Shkreli Securities Fraud Trial
Tech‘Pharma Bro’ Martin Shkreli Heads to Jail For Placing Bounty on Hillary Clinton’s Hair
By ReutersSeptember 13, 2017
Key Speakers At 16th Nikkei Global Management Forum 2014
HealthStruggling Israeli Generics Maker Teva Finally Names New CEO
By Natasha BachSeptember 11, 2017
CNBC Events
HealthBotox Maker Allergan’s CEO Defends Selling Drug Patents to Native American Tribe to Thwart Rivals
By Sy MukherjeeSeptember 9, 2017
Former Turing Pharmaceuticals CEO Martin Shkreli On Trial For Securities Fraud
LeadershipProsecutors Want Martin Shkreli Jailed After Hillary Clinton Hair ‘Threat’
By Lucinda ShenSeptember 8, 2017
Businessman with Duchenne muscular dystrophy in a motorized wheelchair working in an office
HealthThis Controversial Biotech May Yet Defy Its Skeptics
By Sy MukherjeeSeptember 6, 2017
Novartis CEO Joe Jimenez Interview and Tour of $1 Billion Research Center
HealthNovartis CEO Joseph Jimenez Is Stepping Down
By David MeyerSeptember 4, 2017
Is $475,000 Too High a Price for Novartis’s ‘Historic’ Cancer Gene Therapy?
HealthIs $475,000 Too High a Price for Novartis’s ‘Historic’ Cancer Gene Therapy?
By Sy MukherjeeAugust 31, 2017
Novartis CEO Joe Jimenez Interview and Tour of $1 Billion Research Center
HealthThe Way We Treat Cancer Will Be Revolutionized As Gene Therapy Comes to the U.S.
By Sy MukherjeeAugust 30, 2017
Elijah Cummings, Peter Welch
HealthHouse Democrats Start Multiple Sclerosis Drug Price Probe
By BloombergAugust 17, 2017
1...
  • 54
  • 55
  • 56
  • 57
  • 58
...100
Most Popular
Politics
'This is the last warning.' Iran threatens U.S. warships after they throw down the gauntlet for winner-take-all Strait of Hormuzplaceholder alt text
By Fortune EditorsApril 11, 2026
Economy
'People are trying to be creative': Tariff-battered American companies are so cash-starved they are using refund claims as collateral for loansplaceholder alt text
By Fortune EditorsApril 12, 2026
Real Estate
A 93-year-old refused to sell her home to the Masters golf course that’s spent $280 million on expansion: ‘Money ain’t everything’placeholder alt text
By Fortune EditorsApril 12, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.